Skip to main content

Table 2 Distribution of patients according to the dose of fotemustine received

From: Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Group

Induction dose, mg/m2 (no. pts)

Maintenance dose, mg/m2 (no. of pts)

All pts no. = 40

A

65 (5)

75 (5)

5

B

75 (15)

75 (10) – 85 (5)

15

C

85 (10) – 100 (10)

75/85 (18) – 100 (2)

20

  1. no., number; pts, patients